Cita APA

Hirayama, Y., Tam, T., Jian, K., Andersen, R. J., & Sadar, M. D. (2020). Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer. Mol Oncol.

Chicago Style Citation

Hirayama, Yukiyoshi, Teresa Tam, Kunzhong Jian, Raymond J. Andersen, i Marianne D. Sadar. "Combination Therapy With Androgen Receptor N‐terminal Domain Antagonist EPI‐7170 and Enzalutamide Yields Synergistic Activity in AR‐V7‐positive Prostate Cancer." Mol Oncol 2020.

Cita MLA

Hirayama, Yukiyoshi, et al. "Combination Therapy With Androgen Receptor N‐terminal Domain Antagonist EPI‐7170 and Enzalutamide Yields Synergistic Activity in AR‐V7‐positive Prostate Cancer." Mol Oncol 2020.